Stimulus Hopes Rise...
Health Care: Drugs
Abbott Laboratories (ABT: NYSE)
$60.22 -0.30 | -0.50%
06/04/12 - 04:02 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 18.70 | 17.40 | 17.70 |
| P/E High - Last 5 Yrs | 25.80 | 19.50 | 67.70 |
| P/E Low - Last 5 Yrs | 11.20 | 8.60 | 12.50 |
| Beta | 0.32 | 0.58 | 0.98 |
| Price to Sales (TTM) | 2.42 | 2.34 | 1.42 |
| Price to Book (MRQ) | 3.74 | 2.46 | 2.41 |
| Price to Tangible Book (MRQ) | -393.54 | 19.23 | 5.08 |
| Price to Cash Flow (TTM) | 11.70 | 9.60 | 9.80 |
| Price to Free Cash Flow (TTM) | 29.10 | 89.50 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 3.40 | 4.40 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | 3.00 | 3.50 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | 9.70 | 5.99 | -0.76 |
| Payout Ratio (TTM) | 59.00 | 69.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 4.60 | 23.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 10.50 | 12.50 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 10.50 | 4.23 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 43.80 | 61.90 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 43.80 | 61.90 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | 10.34 | 0.81 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -2.63 | 14.94 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.00 | 1.40 | 1.10 |
| Current Ratio (MRQ) | 1.50 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.47 | 0.36 | 0.82 |
| Total Debt to Equity (MRQ) | 0.65 | 0.46 | 0.96 |
| Interest Coverage (TTM) | 12.00 | 12.00 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 68.50 | 77.40 | 46.90 |
| Gross Margin - 5 Yr Avg | 65.10 | 78.40 | 47.70 |
| EBITD Margin (TTM) | 24.90 | 30.50 | 18.90 |
| EBITD - 5 Yr Avg | 25.67 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 14.40 | 21.30 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 17.70 | 23.10 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.13 | 0.17 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 14.70 | 19.00 | 7.00 |
| Return on Assets (TTM) | 8.20 | 7.40 | 3.10 |
| Return on Assets - 5 Yr Avg | 9.30 | 9.80 | 2.50 |
| Return on Investment (TTM) | 13.70 | 11.50 | 7.90 |
| Return on Investment - 5 Yr Avg | 14.80 | 15.70 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 431,506.00 | 548,710.00 | 449,376.00 |
| Net Income/Employee (TTM) | 56,118.00 | 91,547.00 | 39,003.00 |
| Receivable Turnover (TTM) | 5.30 | 4.90 | 7.60 |
| Inventory Turnover (TTM) | 3.60 | 1.90 | 8.30 |
| Asset Turnover (TTM) | 0.60 | 0.50 | 0.40 |
Portfolios with ABT
- Portfolio NameUser Type
- ContributorRocket Stocks for the Week ...
- Contributor10 Best-Performing 'Dividen...
- Contributor3 Upcoming Spinoffs That Co...
- UserBen's Growth Dividend Stocks
- Userlj's Portfolio
- UserPerpetual growers
- UserEyeon
- UserStock
- Userdiz
- ContributorHighest-Yielding Drug Stocks
Latest ABT Headlines from TheStreet
- 5 Rocket Stocks to Buy in June 06.04.12 | 11:06 am
- 3 Stocks I Saw on TV, June 4
06.04.12 | 08:06 am - Cramer's 'Mad Money' Recap: Europe's Problems a Global Problem 06.01.12 | 07:06 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Loser 06.01.12 | 05:06 pm
- Cramer's 'Mad Money' Recap: Avoid These High-Drama Stocks! 05.30.12 | 08:05 pm
- Cramer on Retirement: Individual Stocks Are Right for Your 401(k) 05.29.12 | 06:05 am
- Abbott Laboratories (ABT): Today's Featured Drugs Loser 05.23.12 | 05:05 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Winner 05.16.12 | 04:05 pm
- Abbott Helps Big Pharma Look Even Worse 05.16.12 | 01:05 pm
- Abbott Laboratories (ABT): Today's Featured Health Care Loser 05.09.12 | 05:05 pm
Press Releases for ABT
- Abbott Again Recognized As One Of The 'Best Places To Work In Industry' By The Scientist Magazine - PR Newswire 06.01.12 | 09:06 am
- Absolute Software Partners With InComm To Sell LoJack For Laptops Through Major U.S. Retailers - PR Newswire 05.31.12 | 07:05 am
- Abbott To Present At Goldman Sachs 33rd Annual Global Healthcare Conference - PR Newswire 05.29.12 | 09:05 am
- Abbott To Present Wide Range Of Investigational Efficacy, Safety And Health Outcomes Data On HUMIRA® (Adalimumab) At The Annual Meeting Of The European League Against Rheumatism - PR Newswire 05.29.12 | 01:05 am
- Absolute Software Awarded Lenovo Top Supplier Award - PR Newswire 05.16.12 | 07:05 am
- Absolute Software Releases Turnkey BYOD Support For All Apple, Android And Windows Mobile Devices, Including Laptops - PR Newswire 05.15.12 | 08:05 am
- Abbott's XIENCE PRIME⢠And XIENCE V® Drug Eluting Stents Receive Indication In Europe For Minimum Three-Month Duration Of Dual Anti-Platelet Therapy - PR Newswire 05.15.12 | 08:05 am
- Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System With Insulin Calculator Now Available In Canada - PR Newswire 05.10.12 | 01:05 am
- Absolute Software Reaches Favourable Settlement Agreement In Precedent Setting Anti-Theft Patent Infringement Case - PR Newswire 05.08.12 | 06:05 pm
- Grant & Eisenhofer Represents Lead Whistleblower In Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing Of Antiepileptic Medication Depakote - PR Newswire 05.07.12 | 02:05 pm
Partner Headlines for ABT
- Healthcare Business Recap: Dendreon BOMBS, Cancer Cures Galore - Wall St. Cheat Sheet 06.04.12 | 06:06 am
- Watchdog: Cramer Tells Investors Buy These 5 Stocks Now! - Wall St. Cheat Sheet 05.31.12 | 09:05 am
- 5 Strong Companies That Increased Yields By More Than 10% Over The Past 3 Years - Seeking Alpha 05.30.12 | 09:05 am
- Mason Hawkins' Southeastern Discusses Abbott Labs - GuruFocus 05.23.12 | 04:05 pm
- Zacks' Voice of the People highlights opportunities with Johnson & Johnson, Disney, Abbott Labs and Church & Dwight - Press Releases - Zacks 05.23.12 | 09:05 am
- Health Care SPDR In Focus Ahead Of Obamacare Decision - Benzinga 05.22.12 | 12:05 pm
- Auxilium-Glaxo to Drive Testim Sales - Analyst Blog - Zacks 05.22.12 | 10:05 am
- Big-Cap Leaders Bland, But Their Charts Holding Up - Investor's Business Daily 05.21.12 | 07:05 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am
